EUVIMEDEUVIMED entdecken
Crossref

Hesperetin-Cu(II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking

Xi Peng, Kai Liu, Xing Hu, Deming Gong, Guowen Zhang

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2023-04 · 290 · 122301

DOI: 10.1016/j.saa.2022.122301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023-04. Verfasst von Xi Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; Jiangxi Biotech Vocational College, Nanchang 330200…. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Diabetes Mellitus. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, State Key Laboratory of Food Science and Technology, Nanchang University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of α-amylase and α-glucosidase activity is an effective way for controlling postprandial blood glucose-related diabetes. The study found that hesperetin-Cu(II) complex (Hsp-Cu(II)) exhibited a stronger inhibitory ability on α-amylase and α-glucosidase compared to hesperetin (Hsp), with smaller IC50 values of Hsp-Cu(II) (60.3 ± 0.9 µM for α-amylase; 1.25 ± 0.03 µM for α-glucosidase) than Hsp (115.6 ± 1.1 µM for α-amylase; 55.2 ± 0.1 µM for α-glucosidase). Interestingly, Hsp-Cu(II) and acarbose exerted a synergistic effect on inhibition of α-glucosidase. The binding affinities of Hsp-Cu(II) to α-amylase and α-glucosidase were strong with the Ka values (binding constant) in the magnitude order of 105, which was 9 times larger than Hsp. After interacting, Hsp-Cu(II) reduced α-helix contents of α-amylase and α-glucosidase, resulting in a looser conformation of these two enzymes. Molecular simulations manifested that Hsp-Cu(II) bound to the active center of enzymes driven by hydrogen bonds and interacted with the key catalytic amino acids (α-amylase: Gln63, Asp300 and His305; α-glucosidase: Tyr158, Asp215, Glu277 and Glu411), altering the conformation of enzymes, blocking the entrance of substrates, ultimately reducing the activities of α-glucosidase and α-amylase. This study has demonstrated that Hsp-Cu(II) may be a promising candidate of functional nutritional additive and medicine for the prevention of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsDiabetes MellitusHumansMolecular Docking Simulationalpha-Amylasesalpha-GlucosidasesHesperidin

Stichwörter der Autor:innen

FluorescenceHesperetin-Cu(II)Inhibition mechanismMolecular simulationsα-Amylaseα-Glucosidase

Substanzen

Glycoside Hydrolase Inhibitorsalpha-Amylasesalpha-GlucosidaseshesperetinHesperidin

Autor:innen und Institutionen

  • State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; Jiangxi Biotech Vocational College, Nanchang 330200, China.
  • State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
  • State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China. Electronic address: gwzhang@ncu.edu.cn.

Förderung

  • Natural Science Foundation of Jiangxi Province
  • State Key Laboratory of Food Science and Technology, Nanchang University
  • National Natural Science Foundation of China

Zitieren

APA

Peng, X., Liu, K., Hu, X., Gong, D., & Zhang, G. (2023). Hesperetin-Cu(II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 290, 122301. https://doi.org/10.1016/j.saa.2022.122301

Vancouver

Peng X, Liu K, Hu X, Gong D, Zhang G. Hesperetin-Cu(II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2023;290:122301. doi:10.1016/j.saa.2022.122301

BibTeX
@article{Peng2023,
  author = {Peng, Xi and Liu, Kai and Hu, Xing and Gong, Deming and Zhang, Guowen},
  title = {Hesperetin-Cu(II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking},
  journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
  year = {2023},
  volume = {290},
  pages = {122301},
  doi = {10.1016/j.saa.2022.122301}
}
Kostenlos starten →